Bluejay Diagnostics (BJDX) shares sank 58% after the company overnight said institutional investors agreed to exercise warrants at a "reduced exercise price."
More than 1.77 million shares traded intraday compared with a daily average of about 1.06 million.
CVRx (CVRX) said late Monday it expects to report roughly $12.3 million in Q1 revenue compared with $10.8 million a year ago.
Analysts polled by FactSet, on average, expected $14.7 million.
Shares sank 44% following an increase in intraday trading volume to over 3.34 million from a daily average of more than 244,000.
Price: 3.17, Change: -4.33, Percent Change: -57.73
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.